Anebulo Pharmaceuticals, Inc. (ANEB) Reports In-Line Q4 EPS

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• enVVeno Medical (NVNO) files $100M mixed shelf
• Curvature Securities terminates ATM sales pact with Planet Green